Related Experiment Video
Updated: May 31, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
Lei Huang1, Zheng Yan, Xiaodong Liao
1Department of Medical Genetics, E-Institutes of Shanghai Universities, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. leihuang@shsmu.edu.cn
Abstract:
There are currently two distinct models proposed to explain why both MDM2 and MDMX are required in p53 control, with a key difference centered on whether these two p53 inhibitors work together or independently. To test these two competing models, we generated knockin mice expressing a point mutation MDMX mutant (C462A) that is defective in MDM2 binding. This approach allowed a targeted disassociation of the MDM2/MDMX heterocomplex without affecting the ability of MDMX to bind to p53, and while leaving the MDM2 protein itself completely untouched. Significantly, Mdmx(C462A/C462A) homozygous mice died at approximately day 9.5 of embryonic development, as the result of a combination of apoptosis and decreased cell proliferation, as shown by TUNEL and BrdU incorporation assays, respectively. Interestingly, even though the MDMX mutant protein abundance was found slightly elevated in the Mdmx(C462A/C462A) homozygous embryos, both the abundance and activity of p53 were markedly increased. A p53-dependent death was demonstrated by the finding that concomitant deletion of p53 completely rescued the embryonic lethality in Mdmx(C462A/C462A) homozygous mice. Our data demonstrate that MDM2 and MDMX function as an integral complex in p53 control, providing insights into the nonredundant nature of the function of MDM2 and MDMX.
Insights
The MDM2-MDMX protein complex is essential for controlling p53 levels. Disrupting this complex in mice leads to embryonic death due to increased p53 activity, proving their cooperative function.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- MDM2 and MDMX are key inhibitors of the tumor suppressor p53.
- Two models exist for MDM2-MDMX function: cooperative or independent inhibition of p53.
- Understanding their interaction is crucial for p53 pathway regulation.
Purpose of the Study:
- To investigate the functional relationship between MDM2 and MDMX in p53 regulation.
- To differentiate between models of cooperative versus independent action of MDM2 and MDMX.
- To elucidate the nonredundant roles of MDM2 and MDMX in embryonic development.
Main Methods:
- Generation of knockin mice with an MDMX point mutation (C462A) to disrupt MDM2 binding.
- Assessment of embryonic development, apoptosis (TUNEL assay), and cell proliferation (BrdU incorporation).
- Analysis of p53 protein abundance and activity in mutant embryos.
- Evaluation of p53 deletion to rescue lethality.
Main Results:
- Homozygous Mdmx(C462A/C462A) mice exhibited embryonic lethality around day 9.5.
- Lethality resulted from increased apoptosis and decreased cell proliferation.
- p53 protein abundance and activity were significantly elevated in mutant embryos.
- Deletion of p53 rescued the embryonic lethality, confirming p53-dependent effects.
Conclusions:
- MDM2 and MDMX function as an integral complex for effective p53 control.
- The data support a cooperative model for MDM2 and MDMX action.
- This study highlights the nonredundant and essential roles of the MDM2-MDMX complex in development.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway

